Evidence map›Paper›PMID 33562701›Full record

ArticleMolecules (Basel, Switzerland)2021

Study of Neuroprotection by a Combination of the Biological Antioxidant (

Christine Trabolsi, Wafaa Takash Chamoun, Akram Hijazi, Cendrine Nicoletti, Marc Maresca, Mohamad Nasser

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. In Vitro and In Silico Activities ofMolecules (Basel, Switzerland) · 2023
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Christine TrabolsiNeuroscience Research Center, Faculty of Medical Sciences, Lebanese University, Beirut P.O. Box 6573/14, Lebanon.
Wafaa Takash ChamounNeuroscience Research Center, Faculty of Medical Sciences, Lebanese University, Beirut P.O. Box 6573/14, Lebanon.
Akram HijaziPlateforme de recherche et d'analyse en sciences de l'environnement (EDST-PRASE), Beirut P.O. Box 6573/14, Lebanon.ORCID 0000-0003-4984-8531
Cendrine NicolettiAix Marseille University, CNRS, Centrale Marseille, iSm2, 13397 Marseille, France.ORCID 0000-0002-0086-6707
Marc MarescaAix Marseille University, CNRS, Centrale Marseille, iSm2, 13397 Marseille, France.ORCID 0000-0002-3585-4765
Mohamad NasserRammal Hassan Rammal Research Laboratory, Physiotoxicity (PhyTox), Faculty of Sciences, Lebanese University, Beirut P.O. Box 6573/14, Lebanon.
Lebanese University · LBCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic cerebral ischemia with a notable long-term cessation of blood supply to the brain tissues leads to sensorimotor defects and short- and long-term memory problems. Neuroprotective agents are used in an attempt to save ischemic neurons from necrosis and apoptosis, such as the antioxidant agent

Indexed as

AnimalsAntihypertensive AgentsAntioxidantsBenzimidazolesBiphenyl CompoundsBody WeightBrain IschemiaCarotid Artery, CommonChronic DiseaseDrug InteractionsEucalyptusMorris Water Maze TestNeuroprotective AgentsPlant ExtractsRatsRecognition, PsychologyAntihypertensive AgentsAntioxidantsBenzimidazolesBiphenyl CompoundscandesartanNeuroprotective AgentsPlant ExtractsTetrazolesCandesartanchronic cerebral ischemiaEucalyptusrats

Identifiers

PMID33562701
PMCPMC7915443
OpenAlexW3129007955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.